(917) 310-3371
Telemedicine can make opioid use disorder treatment easier to start, but it still needs a careful medical review, prescription monitoring checks, pharmacy coordination, and a realistic follow-up plan.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking.
A virtual MAT visit can assess opioid use disorder, medication continuity and whether buprenorphine treatment is appropriate. It still needs a clinical evaluation and a plan for pharmacy access, monitoring and in-person care when required. A video or phone appointment does not guarantee a controlled-medication prescription or make injection administration possible remotely.
Be ready to describe the opioids or other products used, last use, withdrawal symptoms, overdose history, current medications and prior treatment. If continuing care, bring the prescription, remaining supply and previous clinician’s records. Tell the clinician about fentanyl, benzodiazepines, alcohol and any missed treatment so the next step reflects current risk.
Tell the service where you will physically be during the visit. As of October 8, 2026, HHS describes federal controlled-medication telemedicine flexibilities through December 31, 2026, subject to required conditions. State law, clinician licensing and registration, clinical judgment, payer requirements and pharmacy rules still matter. Ask whether your visit can use video or phone and whether an in-person evaluation is required for your situation.
If a prescription is appropriate, confirm the receiving pharmacy and a way to address dispensing problems. Sublocade, Brixadi and Vivitrol require healthcare-professional administration; a virtual consultation can assess or coordinate their care but cannot deliver the injection. Physical assessment, testing, withdrawal concerns or an interrupted treatment plan may also require in-person care.
Agree on the next contact, symptom and side-effect review, naloxone access and the plan for missed visits or medication gaps. Discuss counseling and other recovery support. If a pharmacy problem arises, contact the prescriber before improvising a dose or restarting after new opioid use. Emergency overdose or severe symptoms require emergency care, not waiting for the next virtual appointment.
Telemedicine can support an addiction evaluation and follow-up for some patients. For buprenorphine, eligibility depends on clinical need, your location at the visit, applicable prescribing rules and a pharmacy plan. A video appointment can reduce travel, but it does not guarantee a controlled-medication prescription or replace urgent in-person care.
Federal temporary flexibilities for certain controlled-medication prescribing remain extended through December 31, 2026. This is dated context as of October 8, 2026, not a permanent access promise. Federal, state, licensure, DEA, clinical and pharmacy requirements still apply. The clinician must decide whether remote assessment is adequate and whether an examination, test or another setting is needed.
Before scheduling, confirm that the clinician can treat a person physically located in your state at the time of the visit. Tell the team if you will travel or move. Describe urgent symptoms and the reason for seeking care so they can judge whether telemedicine is the appropriate first step.
Bring the medication list, current prescription, last dose, treatment records and pharmacy details. Use a space where you can discuss substance use and symptoms without interruption. Check the video and audio requirements. Ask how to continue if the connection fails; do not assume a technical failure counts as a completed evaluation.
Discuss actual use, symptoms, missed treatment, sedatives and health history. The clinician may request further information, testing or an in-person assessment. If prescribing is appropriate, clarify the product, pharmacy and written initiation or continuation instructions. An online form alone is not the whole clinical decision.
Clarify the next visit, laboratory or in-person needs, refill process and how to report symptoms. Ask what happens if the pharmacy cannot dispense or you are outside the clinician’s permitted service area. Keep an emergency plan appropriate to your current location.
Check what identification and registration records are required. Have medication bottles available and know your current address and physical location. Include recent opioid exposure and the last injection, if any. Arrange sufficient privacy for an honest discussion. Do not begin a home induction or stop another medicine while waiting for a virtual appointment unless your clinician has given an individualized plan.
Call 911 or seek local emergency care for possible overdose, serious breathing problems, seizure, chest pain, severe confusion or inability to stay safe. Virtual messaging is not emergency monitoring. Alcohol and sedatives increase risk with opioids or buprenorphine. If symptoms worsen while awaiting a remote visit, obtain timely in-person assessment rather than assuming the scheduled call is adequate.
Remote follow-up can review symptoms, use, adherence and side effects, but some needs require physical assessment or testing. Confirm how often the clinician reviews the plan and how to request help between visits. A refill is subject to ongoing review. If rules change or you move, plan continuity before the next prescription is due.
Ask whether the service offers new-patient OUD evaluations, continuation visits or both, and which locations and states are eligible. Confirm visit charges, insurance coverage and pharmacy requirements. If you are arranging care for 2027 or later, ask about the rules then in effect. Confirm the actual clinician and pharmacy pathway before relying on remote access.
An appropriate evaluation or follow-up may be possible by video when the clinician is authorized to treat you where you are physically located. The service must confirm age, eligibility and current prescribing requirements. A video visit does not guarantee a controlled-substance prescription. Some examinations and tests need an in-person visit. Provider-administered injections require the appropriate treatment setting. Ask intake where any ordered specimens must be collected. Tell intake your actual location and requested service.
Have your insurance card ready when booking. Share member details through the clinic’s confirmed secure intake process. Check with the clinic and your insurer that the exact plan covers the clinician and requested service. Ask about visit charges, any separately billed tests or medicines, and any referral or authorization requirement. Coverage and your copay or deductible depend on the plan; request a written estimate if paying yourself.
SAMHSA describes a federal pathway that can allow buprenorphine initiation through phone or video telehealth under defined requirements and time limits. Patients can review the public Q&A; from SAMHSA.